DOI: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-031-11700-8 Online ISBN: 978-3-031-11701-5 eBook Packages: MedicineMedicine (R0)
Serious but rare adverse effects may include: Pancreatitis Gallbladder disease Kidney injury Thyroid C-cell tumors (observed in rodent studies) Semaglutide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
For laboratories focused on next-generation therapeutics, retatrutide provides a versatile, high-potency research peptide to explore multi-receptor pharmacology, body composition dynamics, and metabolic rewiring
Well, thanks for the insightful background, Robert
Randomized controlled trial: subcutaneous vs intravenous infliximab CT-P13 maintenance in inflammatory bowel disease
It does not provide medical advice, diagnosis, or treatment